Breaking news: Teva fined €463 million for blocking the market launch of competing MS drugs

By William Janes (October 31, 2024, 11:46 a.m. GMT) — The European Union's antitrust regulator fined pharmaceutical giant Teva 463 million euros ($502 million) on Thursday for a smear campaign against a rival multiple sclerosis drug launched and it abused the patent system to thwart its competitor's attempt to enter the market….

Law360 is there, so you are too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments, so you can act quickly and confidently. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.

A Law360 subscription includes features like

• Daily newsletters
• Expert analysis
• Mobile app
• Advanced search
• Information about the judge
• Real-time alerts
• Over 450,000 searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.